A comparison between antihypertensive medication adherence and treatment intensification as potential clinical performance measures

Circulation: Cardiovascular Quality and Outcomes

Volumn 5, Issue 3, 2012, Pages 276-282

  Vigen, Rebecca ^a   Shetterly, Susan ^b   Magid, David J ^b   O'Connor, Patrick J ^c   Margolis, Karen L ^c   Schmittdiel, Julie ^d   Ho, Michael ^a,e  

^a UNIVERSITY OF COLORADO   (United States)

^b KAISER PERMANENTE   (United States)

^c HEALTHPARTNERS RESEARCH FOUNDATION   (United States)

^d DIVISION OF RESEARCH   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Hypertension; Medication adherence; Performance measures; Quality of care; Treatment intensification

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRIORITY JOURNAL;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; ODDS RATIO; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); QUALITY INDICATORS, HEALTH CARE; REGISTRIES; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84864593067     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.112.965665     Document Type: Article

References (17)

1. http://www.qualityforum.org/MeasureDetails.aspx?actid-0&SubmissionId- 880#k-adherence. Accessed April 19, 2012.
2. Drozda J, Messer JV, Spertus J, Abramowitz B, Alexander K, Beam CT, Bonow RO, Burkiewcz JS, Crouch M, Goff DC, Hellman R, James T, King ML, Machado EA, Ortiz E, O'Toole M, Persell ST, Pines JM, Rybicki FJ, Sadwin LB, Sikkema JD, Smith PK, Torcson PJ, Wong JB. ACCF/AHA/AMA-PCPI 2011 performance measures for adults with coronary artery disease and hypertension. Circulation. 2011;124: 248-270.
3. Selby JV, Uratsu CS, Fireman B, Schmittdiel JA, Peng T, Rodondi N, Karter AJ, Kerr EA. Treatment intensification and risk factor control: toward more clinically relevant quality measures. Med Care. 2009;47: 395-402.
4. Rodondi N, Peng T, Karter AJ, Bauer DC, Vittinghoff E, Tang S, Pettitt D, Kerr EA, Selby JV. Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus. Ann Intern Med. 2006;144:475-484.
5. Virani SS, Woodard LD, Chitwood SS, Landrum CR, Urech TH, Wang D, Murawsky J, Ballantyne CM, Petersen LA. Frequency and correlates of treatment intensification for elevated cholesterol levels in patients with cardiovascular disease. Am Heart J. 2011;162:725-732.
6. Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V, Borghi C, Brignoli O, Caputi AP, Cricelli C, Mantovani LG. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation. 2009;120: 1598-1605.
7. Fung V, Huang J, Brand R, Newhouse JP, Hsu J. Hypertension treatment in a Medicare population: adherence and systolic blood pressure control. Clin Ther. 2007;29:972-984.
8. Schmittdiel JA, Uratsu CS, Karter AJ, Heisler M, Subramanian U, Mangione CM, Selby JV. Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification. J Gen Intern Med. 2008;23:588-594.
9. Selby JV, Peng T, Karter AJ, Alexander M, Sidney S, Lian J, Arnold A, Pettitt D. High rates of co-occurrence of hypertension, elevated lowdensity lipoprotein cholesterol, and diabetes mellitus in a large managed care population. Am J Manag Care. 2004;10:163-170.
10. Rose AJ, Berlowitz DR, Manze M, Orner MB, Kressin NR. Comparing methods of measuring treatment intensification in hypertension care. Circ Cardiovasc Qual Outcomes. 2009;2:385-391.
11. Spertus JA, Eagle KA, Krumholz HM, Mitchell KR, Normand S.-L.T. American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care. J Am Coll Cardiol. 2005; 45:1147-1156.
12. Bramley T, Philip PG, Nightengale BS, Frech-Tamas F. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm. 2006;12: 239-245.
13. Ho PM, Magid DJ, Shetterly SM, Olson KL, Peterson PN, Masoudi FA, Rumsfeld JS. Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease. Arch Intern Med. 2008;168:271-276.
14. Maddox TM, Ross C, Tavel HM, Lyons EE, Tillquist M, Ho PM, Rumsfeld JS, Margolis KL, O'Connor PJ, Selby JV, Magid DJ. Blood pressure trajectories and associations with treatment intensification, medication adherence, and outcomes among newly diagnosed coronary artery disease patients. Circ Cardiovasc Qual Outcomes. 2010;3:347-357.
15. Bonow RO, Masoudi FA, Rumsfeld JS, Delong E, Estes NA III, Goff DC Jr, Grady K, Green LA, Loth AR, Peterson ED, Pina IL, Radford MJ, Shahian DM. ACC/AHA classification of care metrics: performance measures and quality metrics: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. J Am Coll Cardiol. 2008;52:2113-2117.
16. Rose AJ, Berlowitz DR, Manze M, Orner MB, Kressin NR. Intensifying therapy for hypertension despite suboptimal adherence. Hypertension. 2009;54:524-529.
17. Giugliano D, Esposito K. Clinical inertia as a clinical safeguard. JAMA. 2011;305:1591-1592.